194 related articles for article (PubMed ID: 29479196)
1. Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial.
Olivier F; Nadeau S; Bélanger S; Julien AS; Massé E; Ali N; Caouette G; Piedboeuf B
Paediatr Child Health; 2017 Jun; 22(3):120-124. PubMed ID: 29479196
[TBL] [Abstract][Full Text] [Related]
2. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
[TBL] [Abstract][Full Text] [Related]
3. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive surfactant therapy
Elbaz Y; Portnov I; Lurie-Marcu B; Shinwell ES
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6802-6806. PubMed ID: 34024234
[TBL] [Abstract][Full Text] [Related]
5. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Goss KCW; Tauscher MK; Murthy V; Ali SKM; Clark HW; Soll RF; Johnson S; Cheong JLY; Carlin JB; Davis PG;
JAMA; 2023 Sep; 330(11):1054-1063. PubMed ID: 37695601
[TBL] [Abstract][Full Text] [Related]
6. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
[TBL] [Abstract][Full Text] [Related]
8. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
Gupta BK; Saha AK; Mukherjee S; Saha B
Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
[TBL] [Abstract][Full Text] [Related]
10. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
Lemyre B; Deguise MO; Benson P; Kirpalani H; Ekhaguere OA; Davis PG
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD005384. PubMed ID: 37466143
[TBL] [Abstract][Full Text] [Related]
11. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol.
Zhang H; Li J; Zeng L; Gao Y; Zhao W; Han T; Tong X
Front Pediatr; 2022; 10():968462. PubMed ID: 35967549
[TBL] [Abstract][Full Text] [Related]
13. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
[TBL] [Abstract][Full Text] [Related]
14. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
15. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
Lemyre B; Laughon M; Bose C; Davis PG
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD005384. PubMed ID: 27976361
[TBL] [Abstract][Full Text] [Related]
16. Continuous distending pressure for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
[TBL] [Abstract][Full Text] [Related]
17. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial.
Kandraju H; Murki S; Subramanian S; Gaddam P; Deorari A; Kumar P
Neonatology; 2013; 103(2):148-54. PubMed ID: 23235135
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive surfactant therapy for moderate to late premature neonates with respiratory distress syndrome born in a non-tertiary unit.
Tinoco Mendoza G; Allgood C; Tan A
J Paediatr Child Health; 2021 Oct; 57(10):1658-1661. PubMed ID: 34021656
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive surfactant therapy failure: risk factors and outcome.
Janssen LC; Van Der Spil J; van Kaam AH; Dieleman JP; Andriessen P; Onland W; Niemarkt HJ
Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F636-F642. PubMed ID: 31036700
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
